title: Prognosis of economy class syndrome treated in intensive care unit.
abstract: OBJECTIVE
  The aim of this study was to clarify the prognosis of economy class syndrome (pulmonary thromboembolism following long distance flight) patients discharged from the intensive care unit.
  
  
  METHODS
  Medications, daily activities, recurrence of pulmonary thromboembolism, and quality of life were investigated for an average of 471 days following discharge from the intensive care unit. The information from the patients was obtained by means of a mailed questionnaire or telephone interview.
  
  
  METHODS
  Ten patients with economy class syndrome were enrolled in this study. Nine were female and one was male (61+/-9 years).
  
  
  RESULTS
  In addition to appropriate acute care, additional management was given including the placement of an inferior vena cava filter in 3 patients and a course of oral anticoagulation therapy in 7 patients. None of them died or had recurrence of pulmonary thromboembolism. Four patients took subsequent air flights. No thromboembolic episodes were seen during the follow-up period.
  
  
  CONCLUSIONS
  The long-term prognosis in these patients can be favorable with appropriate management of the acute episode in conjunction with adequate preventive measures.
authors.affiliation: Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School, Inba.
authors.forename: Noritake
authors.initials: N
authors.lastname: Hata
authors.forename: Keiji
authors.initials: K
authors.lastname: Tanaka
authors.forename: Takahiro
authors.initials: T
authors.lastname: Imaizumi
authors.forename: Takayoshi
authors.initials: T
authors.lastname: Ohba
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Ohara
authors.forename: Takuro
authors.initials: T
authors.lastname: Shinada
authors.forename: Shinya
authors.initials: S
authors.lastname: Yokoyama
authors.forename: Toshirou
authors.initials: T
authors.lastname: Makino
authors.forename: Teruo
authors.initials: T
authors.lastname: Takano
mesh_terms: D000208:Acute Disease; D000337:Aerospace Medicine; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003422:Critical Care; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007362:Intensive Care Units / Q000706:statistics & numerical data*; D007564:Japan / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality / Q000628:therapy; D011788:Quality of Life; D012008:Recurrence; D011795:Surveys and Questionnaires; D013577:Syndrome; D015912:Thrombolytic Therapy; D014195:Travel; D016306:Vena Cava Filters
chemical_list: D000925:Anticoagulants